Dr. Henrike Brundiek ist the new Head of R&D at Enzymicals AG
Dr. Brundiek is a long-term employee of Enzymicals AG and takes over the scientific management of the company from now on. The former CSO, Dr. Rainer Wardenga, steps down from the managing board due to a longer-term parental leave. This decision was made by mutual agreement between the bodies of Enzymicals AG and reflects the family-friendliness of the company.

Dr. Henrike Brundiek
Enzymicals AG
With this restructuring, Dr. Ulf Menyes is the company's sole managing director. He will be supported by Steffen Weber, a long-term colleague and qualified economist.
Dr. Wardenga will focus on management of business development after parental leave. The reorganization of these responsibilities takes into account the steady growth of the company.
Most read news
Other news from the department people

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.